In the breast cancer cell line, the transcription of ADAM19 (a disintegrin and metalloproteinase-domain-containing protein 19), a cancer-associated gene, increases by H2BE76K mutation through facilitation of transcription elongation processes (Kang et al., 2021). This evidence concerns the gene ADAM19 and breast carcinoma.